🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans

Daniel Brims

Stock Analyst at Lake Street

(0.07)
# 4,920
Out of 5,189 analysts
32
Total ratings
14.3%
Success rate
-38.5%
Average return

Stocks Rated by Daniel Brims

AbCellera Biologics
Nov 18, 2026
Initiated Coverage: Buy
Price Target: $19
Current: $9.69
Upside: +96.08%
Kyntra Bio
Nov 17, 2026
Reiterated: Buy
Price Target: $41 → $8
Current: $1.56
Upside: +412.82%
Rezolute
Nov 16, 2026
Reiterated: Buy
Price Target: $12 → $15
Current: $3.92
Upside: +282.65%
Viking Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: $89
Current: $24.77
Upside: +259.31%
Spruce Biosciences
Sep 17, 2026
Initiated Coverage: Buy
Price Target: $149
Current: $38.00
Upside: +292.11%
Kura Oncology
Sep 10, 2026
Reiterated: Buy
Price Target: $23
Current: $6.91
Upside: +232.85%
Aligos Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $45
Current: $1.22
Upside: +3,588.52%
Rani Therapeutics Holdings
May 18, 2026
Reiterated: Buy
Price Target: $9
Current: $0.5111
Upside: +1,660.91%
Lite Strategy
Sep 2, 2015
Reiterated: Buy
Price Target: $7
Current: $0.8026
Upside: n/a
Imunon
Aug 10, 2015
Reiterated: Buy
Price Target: $7
Current: $0.5355
Upside: n/a
Reiterated: Buy
Price Target: n/a
Current: $11.81
Upside: n/a